Who To Contact
Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207
Andres Alvarez, MD, PhD, EMHA
Research Director
Baptist MD Anderson Clinical Trials
Clinical Trial ID: NCT06486441
A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy (ASCENT-GYN-01 / GOG-3104 / ENGOT-en26 / GS-US-682-6769)
Status
Open
Conditions
Other
Phases
3
Age Group
Adult
Main Investiagtor
Hand, Lauren
Practice
Gyn
Scope
National
Nct ID Number
NCT06486441
Secondary Trial ID Number
GS-US-682-6769 / GOG-3104
Keywords
Treatment